Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Marie Skłodowska-Curie Action · Ended early

GlycoGuard Deciphering Glycosphingolipids as Drivers of a Novel Cell-Autonomous Immune Response

Coordinator
Goeteborgs Universitet, Sweden
Runs
1 October 2025 to 30 September 2028
Status
Ended early
EU funding
€442k
Total cost
—
Partners
3 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101207174

What the project is doing

In the project's own words, from its summary on CORDIS.

Pathogens exploit glycosphingolipids (GSLs) on the surface of gut epithelial cells to initiate infection. A recent breakthrough has uncovered a novel, cell-autonomous immune response in which multivalent clustering of GSLs by bacterial toxins or viruses triggers the degradation of the cell polarity protein PARD6B, leading to reduced pathogen uptake. This novel GSL-PARD6B pathway highlights the critical role of GSLs in mucosal immunity.

However, the precise molecular mechanisms by which GSL binding initiates this intracellular signaling cascade and the subsequent changes to the host membrane composition are not fully understood. By integrating novel biochemical techniques with my existing skills in GSL-pathogen research, I will: 1)Define the triggering mechanism of the GSL-PARD6B pathway and, 2)Determine the effects of the microbiota and the GSL-PARD6B pathway on plasma membrane composition.

This work will reveal how extracellular signals are translated across the plasma membrane to modulate intracellular responses and uncover mechanisms that protect against infection. Overall, the GlycoGuard project intends to provide a comprehensive understanding of the GSL-PARD6B pathway, advancing our knowledge of host-pathogen interactions and paving the way for novel therapeutic strategies against infections. Additionally, this grant will enhance my skills as a researcher and provide the foundation to establish myself as an independent scientist.

Topics

Who is involved

OrganisationCityCountryRole
Goeteborgs UniversitetGoeteborgSwedenCoordinator
Children's Hospital CorporationBostonUnited StatesAssociatedpartner
Johns Hopkins UniversityBaltimoreUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI